What is Phenotap?
Phenotap Inc. is at the forefront of non-invasive continuous ketone monitoring, offering consumers a simple method to track Beta-HydroxylButyrate (BHB) levels directly via their smartphones. The innovative device provides hourly insights into ketone concentrations, empowering users to make personalized dietary adjustments for enhanced wellness objectives. The company champions 'Cognizant Nutrition,' emphasizing the critical role of personalized nutrition measurement in achieving holistic health benefits. Through strategic collaborations with experts in metabolic health and wearable technology, Phenotap is driving advancements in consumer-focused health solutions.
How much funding has Phenotap raised?
Phenotap has raised a total of $3M across 1 funding round:
Other Financing Round
$3M
Other Financing Round (2025): $3M with participation from Helmsley Charitable Trust
Key Investors in Phenotap
Helmsley Charitable Trust
Helmsley Charitable Trust is dedicated to improving healthcare access and advancing research, focusing on areas like Type 1 diabetes and Crohn's disease. Their involvement suggests a strategic interest in health technology and metabolic wellness solutions that align with their mission to enhance quality of life.
What's next for Phenotap?
The recent major strategic investment signals Phenotap's transition into a scaling phase, likely enabling the company to expand its market reach, further develop its technology, and potentially broaden its product offerings. This enterprise-level funding suggests confidence from investors in Phenotap's business model and its potential to capture a significant share of the growing personalized nutrition and wellness market. Future growth may involve enhancing the user experience, forging new partnerships, and solidifying its position as a leader in continuous metabolic health monitoring.
See full Phenotap company page
